Non-bacterial thrombotic endocarditis primary prevention: Difference between revisions
Homa Najafi (talk | contribs) No edit summary |
Aisha Adigun (talk | contribs) |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{Aisha}} | {{CMG}}; {{AE}}{{Aisha}} | ||
==Overview== | ==Overview== | ||
There are no established measures for the primary prevention of | There are no established measures for the primary prevention of non-bacterial thrombotic endocarditis. | ||
==Primary Prevention== | ==Primary Prevention== |
Revision as of 21:10, 22 August 2020
non-bacterial thrombotic endocarditis |
Differentiating non-bacterial thrombotic endocarditis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Non-bacterial thrombotic endocarditis primary prevention On the Web |
American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis primary prevention |
FDA on Non-bacterial thrombotic endocarditis primary prevention |
CDC on Non-bacterial thrombotic endocarditis primary prevention |
Non-bacterial thrombotic endocarditis primary prevention in the news |
Blogs on Non-bacterial thrombotic endocarditis primary prevention |
Risk calculators and risk factors for Non-bacterial thrombotic endocarditis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]
Overview
There are no established measures for the primary prevention of non-bacterial thrombotic endocarditis.
Primary Prevention
There are no established measures for the primary prevention of [disease name].
OR
There are no available vaccines against [disease name].
OR
Effective measures for the primary prevention of [disease name] include:
- [Measure1]
- [Measure2]
- [Measure3]
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]